Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D1U5BA
|
|||
| Drug Name |
Remestemcel-L
|
|||
| Synonyms |
MSC-100-IV
Click to Show/Hide
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Crohn disease [ICD-11: DD70; ICD-10: K50, K50.9; ICD-9: 555] | Phase 3 | [1] | |
| Graft-versus-host disease [ICD-11: 4B24; ICD-9: 279.5] | Phase 3 | [2] | ||
| Company |
Mesoblast
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01233960) Evaluation of PROCHYMAL for Treatment-refractory Moderate-to-severe Crohn's Disease. U.S. National Institutes of Health. | |||
| REF 2 | ClinicalTrials.gov (NCT02652130) Safety Follow-up of Treatment With Remestemcel-L in Pediatric Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.